Table 1 Patients’ demographic and clinical characteristics (N = 39)
Variable | n (%) |
|---|---|
Age (years) | 45.6 |
Sex | |
Male | 32 (82.05%) |
Female | 7 (17.95%) |
Duration of symptoms (days) | 4.6 |
Affected sites | |
Upper extremities | 6 (18.18%) |
Lower extremities | 33 (84.62%) |
Causative organism(s) | |
Gram positive bacteria | |
Staphylococcus aureus | 18 (46.15%) |
Methicillin-resistant Staphylococcus aureus | 2 (5.13%) |
Enterococcus faecalis | 1 (2.56%) |
Enterococcus faecium | 2 (5.13%) |
Streptococcus anginosus | 3 (7.69%) |
Staphylococcus epidermidis | 4 (10.26%) |
Streptococcus agalactiae | 1 (2.56%) |
Coagulase-negative staphylococci | 1 (2.56%) |
S. constella subsp. constellatus | 1 (2.56%) |
Enterococcus avium | 1 (2.56%) |
Gram negative bacteria | |
Klebsiella pneumoniae | 2 (5.13%) |
Enterobacter cloacae | 5 (12.82%) |
Pseudomonas aeruginosa | 3 (7.69%) |
Acinetobacter baumannii | 4 (10.26%) |
Escherichia coli | 5 (12.82%) |
Negative results of culture | 6 (15.38%) |
Comorbidities | |
Diabetes mellitus | 13 (33.33%) |
Liver cirrhosis/Chronic hepatitis | 1 (2.56%) |
Burns | 2 (5.13%) |
Insect bite | 1 (2.56%) |
Rash | 1 (2.56%) |
Blunt trauma | 9 (23.08%) |
Cancer | 1 (2.56%) |
Pressure injury | 2 (5.13%) |
Erythema nodosum | 1 (2.56%) |
Skin infection/adscess | 5 (12.82%) |
Use of nonsteroidal anti-inflammatory drugs | 1 (2.56%) |
Idiopathic/no comorbidities | 5 (12.82%) |
LRINEC score positive | 18 (46.15%) |